Roche warns of shortage of Covid-19 drug tocilizumab - The Hindu BusinessLine
FDA approves drug to treat CRS induced by CAR T-cell therapy | MDedge Hematology and Oncology
WHO Urges Covid-19 Treatment With Roche and Sanofi Anti-Inflammatory Drugs - WSJ
Tocilizumab erhält Zulassungsempfehlung | Gelbe Liste
Tocilizumab erhält Zulassungsempfehlung | Gelbe Liste
Covid-19-Medikament von Roche wird für den Grossteil der Welt unerschwinglich bleiben | Ärzte ohne Grenzen (MSF)
Actemra RoActemra Tocilizumab Roche 400 MG 20ML | Indian Business Portal
Patientenbroschüre für Erwachsene
Delhi HC Issues Order on Tocilizumab Shortage, Seeks Patent Working Information from Roche – SpicyIP
Roche | Actemra
Tocilizumab: Rheumamedikament senkt Corona-Sterblichkeit - WELT
Tocilizumab als Therapie bei schwerer COVID-19 zugelassen
Approval lapsed) RoActemra tocilizumab 80mg/4mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
CHMP backs expanded approval of tocilizumab | MDedge Hematology and Oncology
Tocilizumab Injection Supply: Delhi HC asks Centre to hold meeting with Roche to ensure immediate supply of Tocilizumab - The Economic Times
Roche Holding – Wikipedia
RoActemra (Tocilizumab) Beobachtungsplan ML29087
Genentech's arthritis drug tocilizumab shows promise in Covid-19 trial
Rote-Hand-Brief zu RoActemra® (Tocilizumab)
RoACTEMRA®
RoActemra® 162 mg 4 St mit dem E-Rezept kaufen - SHOP APOTHEKE
Buy RoActemra (tocilizumab) Online • Price & Costs
RoActemra® 162 mg 12 St mit dem E-Rezept kaufen - SHOP APOTHEKE
Tocilizumab bei schwerem Covid-19 zugelassen
